Press release
Ovarian Cancer Market Projected to Reach USD 35.00 Billion by 2034, Growing at a CAGR of 24.1%
Ovarian Cancer Market
Market Preface:
Ovarian cancer is the uncontrolled growth of abnormal cells in the ovaries. The cells proliferate rapidly and can invade and destroy healthy body tissues. Ovarian cancer commences when cells in or proximity to ovaries advance alterations in their DNA. A cell's DNA comprises the directives that command the cells what to do. Mutations in this genetic code cause the cells to grow and divide uncontrollably, forming a tumor.
For premature-phase cancer that has not advanced over the sole avary, surgery may include removing the impacted avary and its fallopian tube. This process may protect the capacity for reproduction. If the cancer is prevalent in both ovaries but there is no indication of further cancer, the surgeon may remove both ovaries and both fallopian tubes. The process saves the uterus so as to have a pregnancy with frozen embryos and eggs.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/ovarian-cancer-market/request-for-sample
Growth Drivers:
Growing Consciousness of Ovarian Cancer: The growing awareness of ovarian cancer is notably driving the market growth. As per the World Cancer Research Fund, ovarian cancer ranked as the eighth most prevalent cancer in women worldwide, with roughly 313000 cases detected in 2020. The growing existence is attributed to factors such as aging population, genetic susceptibility, and lifestyle-related changes involving obesity and hormone replacement therapies, creating a maximized ovarian cancer demand.
Progression of Targeted Therapies: The advancement of targeted therapy, especially poly (ADP-ribose) polymerase (PARP) inhibitors and angiogenesis inhibitors, has fueled the market development. PARP inhibitors, such as olaparib and niraparib, have demonstrated efficacy in patients having BRCA mutations, notably enhancing advancement-free endurance.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/ovarian-cancer-market/request-for-discount-pricing
Competitive Landscape:
The competitive landscape of the market is portrayed by an assortment of pharmaceutical firms, biotechnology firms, and academic bodies diligently involved in the research, development, and commercialization of cures and remedies. The list of key companies profiled are:
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca PLC
• Clovis Oncology, Inc.
• Eli Lilly and Company
• GlaxoSmithKline plc
• Janssen Pharmaceuticals
• Merck & Co., Inc.
• Novartis AG
• Roche Holding AG
Ovarian Cancer Industry Developments
November 2024: Researchers at the Wistar Institute Unveil a New Combination Therapy for Metastatic Ovarian Cancer
Buy Now:
https://www.polarismarketresearch.com/buy/326/0
Market Segmentation:
The ovarian cancer market segmentation is done on the basis of type, treatment type, end user, and region.
By type analysis, the epithelial ovarian cancer segment held the largest market share in 2024 due to epithelial ovarian cancer. It is frequently detected at a progressive phase because of the dearth of premature indications.
By treatment type analysis, the chemotherapy segment led the market in 2024 due to its established role in both first-line and repeated disease handling.
By Type Outlook (Revenue - USD Billion, 2020-2034)
• Epithelial Ovarian Cancer
• Germ Cell Ovarian Cancer
• Stromal Cell Ovarian Cancer
By Treatment Type Outlook (Revenue - USD Billion, 2020-2034)
• Immunotherapy
• Chemotherapy
• Targeted Therapy
• Surgery
• Others
By End User Outlook (Revenue - USD Billion, 2020-2034)
• Hospitals
• Homecare
• Speciality Centre
• Others
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/ovarian-cancer-market
Regional Analysis:
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
Browse More Research Reports:
Programmed Nano Drones Market:
https://www.polarismarketresearch.com/industry-analysis/programmed-nano-drones-market
EV Battery Market:
https://www.polarismarketresearch.com/industry-analysis/electric-vehicle-battery-market
Application Modernization Services Market:
https://www.polarismarketresearch.com/industry-analysis/application-modernization-services-market
Landscaping Services Market:
https://www.polarismarketresearch.com/industry-analysis/landscaping-services-market
Carbon Prepreg Market:
https://www.polarismarketresearch.com/industry-analysis/carbon-prepreg-market
AI for Sales & Marketing Market:
https://www.polarismarketresearch.com/industry-analysis/ai-for-sales-and-marketing-market
Industrial Fasteners Market:
https://www.polarismarketresearch.com/industry-analysis/global-industrial-fasteners-market
Artificial Intelligence in Cancer Diagnostics Market:
https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-in-cancer-diagnostics-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Market Projected to Reach USD 35.00 Billion by 2034, Growing at a CAGR of 24.1% here
News-ID: 3990031 • Views: …
More Releases from Polaris Market Research & Consulting
Decentralized Workforce Tools Market Size to Hit USD 76.38 Billion by 2034 with …
The decentralized workforce tools market is poised to register a CAGR of 6.8% from 2025 to 2034. The market was valued at USD 39.62 billion in 2024. It is anticipated to grow to USD 76.38 billion by 2034.
Market Overview:
Decentralized workforce tools refer to technologies and strategies that enable collaboration, communication, and work management within a distributed or remote workforce. These tools allow employees to work effectively across different locations…
Creator Economy Platforms Market to Reach USD 701.06 Billion by 2034, Growing at …
The market for creator economy platforms is poised to witness substantial growth in the coming years, according to the latest research report by Polaris Market Research. The market was valued at USD 161.97 billion in 2024 and is anticipated to grow to USD 701.06 billion by 2034. It is projected to exhibit a compound annual growth rate (CAGR) of 15.8% during 2025-2034.
What Are Creator Economy Platforms?
Creator economy platforms are digital…
FinTech Market Poised for Significant Growth Expected to Reach US$ 1,537.93 Bill …
The global fintech market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyses the market to account for USD 1,537.93 billion by 2034 and is expected to register a CAGR of 16.3% in the above-mentioned forecast period. The market was valued at USD 340.76 billion in 2024.
Market Overview:
Fintech, short for financial technology, refers to the innovative tools and systems used to perform foundational…
Protein A Resin Market Soars to US$ 2,832.54 Million Experiencing a 6.4% CAGR Bo …
According to Polaris Market Research analysis, the global protein A resin market was valued at USD 1,525.00 million in 2024 and is projected to reach USD 2,832.54 million by 2034, registering a compound annual growth rate (CAGR) of 6.4% from 2025-2034.
Market Introduction:
Protein A resin is an affinity chromatography medium widely used for the efficient purification of monoclonal antibodies (mAbs) and immunoglobulins from cell culture media. In addition to its role…
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms…
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017"
Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150
In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United…
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Ovarian Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
